P
Pascal de Groote
Researcher at university of lille
Publications - 113
Citations - 6651
Pascal de Groote is an academic researcher from university of lille. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 34, co-authored 98 publications receiving 5748 citations. Previous affiliations of Pascal de Groote include University of Paris-Sud & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
Eric Hachulla,Virginie Gressin,Loïc Guillevin,Patrick H. Carpentier,Elisabeth Diot,Jean Sibilia,André Kahan,Jean Cabane,Camille Francès,David Launay,Luc Mouthon,Yannick Allanore,Kiet Tiev,Pierre Clerson,Pascal de Groote,Marc Humbert +15 more
TL;DR: This screening algorithm, based on dyspnea, Doppler echocardiographic evaluation of VTR, and RHC, enabled early detection of PAH at a mild stage and whether this early diagnosis translates into improved prognosis for patients with mild PAH will be evaluated in the ongoing 3-year followup.
Journal ArticleDOI
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure.
Pascal de Groote,Alain Millaire,Claude Foucher-Hossein,Olivier Nugue,X. Marchandise,Gérard Ducloux,Jean-Marc Lablanche +6 more
TL;DR: Multivariate analysis showed that three variables-NYHA classification, percent of maximal predicted VO2 and RVEF-were independent predictors of both survival and event-free cardiac survival.
Journal ArticleDOI
Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure
Regalla Kumarswamy,Christophe Bauters,Ingo Volkmann,Fleur Maury,Jasmin Fetisch,Angelika Holzmann,Gilles Lemesle,Pascal de Groote,Florence Pinet,Thomas Thum +9 more
TL;DR: LIPCAR levels identified patients developing cardiac remodeling and were independently to other risk markers associated with future cardiovascular deaths and predicts future death in patients with heart failure.
Journal ArticleDOI
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Athénaïs Boucly,Athénaïs Boucly,Jason Weatherald,Jason Weatherald,Laurent Savale,Laurent Savale,Xavier Jaïs,Xavier Jaïs,Vincent Cottin,Grégoire Prévot,François Picard,Pascal de Groote,Mitja Jevnikar,Mitja Jevnikar,Emmanuel Bergot,Ari Chaouat,C. Chabanne,Arnaud Bourdin,Florence Parent,Florence Parent,David Montani,David Montani,Gérald Simonneau,Gérald Simonneau,Marc Humbert,Marc Humbert,Olivier Sitbon,Olivier Sitbon +27 more
TL;DR: A simplified risk assessment tool that quantifies the number of low-risk criteria present accurately predicted transplant-free survival in PAH and predicts prognosis at baseline and follow-up.
Journal ArticleDOI
Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival
Marc Humbert,Azzedine Yaici,Pascal de Groote,David Montani,Olivier Sitbon,David Launay,Virginie Gressin,Loïc Guillevin,Pierre Clerson,Gérald Simonneau,Eric Hachulla +10 more
TL;DR: Compared with patients in routine clinical practice, PAH detection programs in SSc are able to identify patients with milder forms of the disease, allowing earlier management.